Pinned Tweet
'Life on a tight rope'
One woman's view of living with vasospastic angina.
BCS conference patients day June 2023.
youtu.be/Tdesy7V_7E0?si=r1Un… – at Barnet, London
Milkfairy 💙 🇺🇦 retweeted
We work towards a world with widespread awareness and informed management of #ANOCA #INOCA #MINOCA #NOCAD #worldHeartDay
#heartPatients
Milkfairy 💙 🇺🇦 retweeted
Session Four of #INOCA2025 looks at how we can build better services and diagnostics for #ANOCA patients.
Talks include:
- Patient Stories
- Setting Up a Service – Dr. Mark Mariathas, Dr. Tusha Kotecha
- Non-Invasive Diagnostics: CMR – Prof. Amedeo Chiribiri
- PET, Echo Doppler, and ETT – Prof. Eva Prescott
Real-world strategies for expanding access to #CMD care.
millbrook-events.co.uk/INOCA…
#INOCA2025 #CMR #ServiceDesign #CardiologyInnovation
Milkfairy 💙 🇺🇦 retweeted
BANCC are pleased to invite you to register for our upcoming webinar 'Angina/Ischemia with Non-Obstructive Coronary Arteries (ANOCA & INOCA) – how to assess, treatment options and the patient perspective' on Wednesday, 15 October 2025 19:00 - 20:20.
members.bancc.org.uk/events/…
Milkfairy 💙 🇺🇦 retweeted
🔊2 weeks to go to INOCA 2025!
📍London SE1 7AR
@TheBHF @NIHRresearch
Incredible international faculty
How to sessions
Guideline updates
Informative talks
Debates
Live cases
Lived experience
Innovations in INOCA
‼️Register ASAP
millbrook-events.co.uk/event…
Milkfairy 💙 🇺🇦 retweeted
' ANOCA progressed from the initial scepticism of the scientific community regarding its existence to the demonstration of its clinical relevance and the need for a standardized diagnostic algorithm (as recommended in current ESC Guidelines)'
academic.oup.com/eurheartj/a…
Milkfairy 💙 🇺🇦 retweeted
📚 Latest News : "Exercise Stress Testing: A Useful Rule-Out Tool in Suspected ANOCA/INOCA"
🔓Access it here 👉 ow.ly/bzAR106ivLh
Milkfairy 💙 🇺🇦 retweeted
Everything you wanted to know about INOCA in 2 days! Well worth registering asap for #INOCA2025, a @TheBHF - @NIHRresearch CV partnership meeting. Stellar international faculty, guideline updates, how to sessions, debates, breaking research, discussion, live cases and more!
Registration is OPEN for #INOCA2025!
🗓️ 25–26 Sept | 📍 London
Join @divaka_perera and @achir76, for two days of cutting-edge insights into Coronary Microvascular Dysfunction.
✅ Live cases
✅ Patient stories
✅ Tech & trials
✅ Real-world clinical tools
Register here: millbrook-events.co.uk/INOCA…
Milkfairy 💙 🇺🇦 retweeted
Persistent angina following PCI. Comprehensive coronary function testing is a valuable tool in diagnosing the underlying cause in patients with no residual CAD @ved5688 #ANOCA #cardiotwitter #AHAJournals ahajrnls.org/3Tcpk6X
Milkfairy 💙 🇺🇦 retweeted
Milkfairy 💙 🇺🇦 retweeted
We are delighted to announce our first educational and Q&A session about Patient and Public Involvement in Research!
➡️Have a question or topic you’d like covered? Let us know and register here by 24th June: forms.office.com/pages/respo…
More info: [email protected]
Milkfairy 💙 🇺🇦 retweeted
Thank you to everyone who passed on the details of our survey.
CONGRATULATIONS to all who took Survey 1! You are, in part, going to the ESC (European Society of Cardiology) Congress with Sarena La on August 29th in Madrid.
@sarena_la
surveys.adelaide.edu.au/redc…
Milkfairy 💙 🇺🇦 retweeted
Congratulation to Her Heart Australia on their 10year Anniversary Event in Melbourne. Our Co Founder Cindy McCall was honored to be on a panel sharing her experiences, creating awareness of what heart disease truly looks like.
Bravo @Heartspasms1 finally meets
@RosannaTavella
Milkfairy 💙 🇺🇦 retweeted
Happy Nurse’s Week!
Thank you to all the nurses who advocate for patients and watch out for them in vulnerable moments! They are the backbone of our care.
Milkfairy 💙 🇺🇦 retweeted
While the umbrella term #ANOCA is useful, it's important to determine whether a person's symptoms are due to microvascular dysfunction, microvessel or coronary artery vasospasms.
1/8
Diltiazem for ANOCA: What’s the real story?
Let’s break down the EDIT-CMD trial and what it does (and doesn’t) tell us about treating coronary vasomotor dysfunction with diltiazem.
#CardioTwitter #ANOCA #CMD
Milkfairy 💙 🇺🇦 retweeted
The WARRIOR trial was ambitious, but without endotyping, outcomes didn’t change.
Dr. Jay Widmer (@DrArgyle) explains why individualized testing is critical for advancing care in INOCA.
🎥 Full breakdown now on YouTube! youtu.be/eequD8jTQhA
#Cardiology #ACC2025 #CathLab
Milkfairy 💙 🇺🇦 retweeted
WARRIOR: Hear From Elizabeth Dineen, DO, FACC, on the WARRIOR trial from #ACC25 which found that intensive medical therapy did 🚫 significantly impact the rate of serious CV events at 5️⃣ years in women w/ suspected INOCA.
🔗 Watch on #ACCAnywhere TV: bit.ly/3FJdX34
Milkfairy 💙 🇺🇦 retweeted
Invasive coronary function testing determination of #INOCA endotypes impacts medical management in patients with angina and no obstructive CAD @YulithRoca @Deeksha_a94 @PaulinaSkaff @DrMarthaGulati @AnaIribarren10 @Baireymerz @WomensHeartCS @SmidtHeart #ACC25
Milkfairy 💙 🇺🇦 retweeted
ICYMI: @BrMenopauseSoc guidance for healthcare professionals
🫀HRT after myocardial infarction thebms.org.uk/wp-content/upl…
🫀Management of menopause for
women with #CVD developed with @scotgov Women’s Health & Heart Health Policy Teams thebms.org.uk/wp-content/upl…
Milkfairy 💙 🇺🇦 retweeted
Good news indeed for patients living with microvascular and vasospastic angina.
Good news for angina and non-obstructive coronary artery (ANOCA)/ischaemia and non-obstructive coronary artery (INOCA) patients: academic.oup.com/ehjopen/art…
#OpenUpYourScience with #EHJOpen
@ESC_Lavinia @ProfMagnusBack @InocaInternati1 @Mary_Galb





































